% | $
Quotes you view appear here for quick access.

Philip Morris International, Inc. Message Board

  • edfiggy edfiggy Jul 31, 2009 4:42 PM Flag

    UBS Downgraded PM this AM. Killed the rally!

    The downgrade caused for PM to move sharply lower from the highs ($47.70) and close lower despite the higher indexes. Bad timing / luck since the US$ heading lower should have helped PM move above $48... It was headed there until our friends from UBS killed the rally.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • fugit_irreparabile_tempus fugit_irreparabile_tempus Aug 1, 2009 10:29 AM Flag

      I wouldn't be to anxious about that rating. This is not the first time that analyst Thomas Kruemmel, UBS AG (thomas. signing such a hazardous analysis.
      He believes exceptionally good growth, unlikely to be maintained. He has probably the better cristall ball than I have.
      My meaning about that is buy on dips and keep. PM is a long term story, the best insurance through the storm of the markets !


      UBS Wealth Management Research: For Individuals
      Ratings : ‡
      Rankings : ‡
      EFVR : Please see latest Corporate Report.
      Sector : Food, Beverage & Tobacco
      Country : United States
      ‡ Rating/Industry Relative Ranking information temporarily suspended due to either a restriction or pending review by the analyst. For further information please contact your financial advisor or representative.

      Research Reports

      For Individuals For Institutions

      UBS Wealth Management Research Reports: For Individuals
      Discontinuation of coverage
      (Jun 17, 2009)
      Philip Morris International : Currency volatility takes its toll; Hold
      (Mar 19, 2009)
      Sector Reports Region Reports Country Reports
      § As part of the Global Research Settlement, UBS and a number of other firms agreed to provide access to Independent Research on certain covered companies to customers in the US for a period of five years, ending July 27, 2009. As of this date, UBS will no longer provide access to Independent Research. However, you will still be able to access reports from UBS Wealth Management Research and UBS Investment Research (from UBS Investment Bank) from your Financial Advisor or from Online Services by selecting the "Research/For Individuals or For Institutions" tabs respectively.

    • Such a wise statement from a young guy. Long term with reinvested dividends PM is a solid, get rich slowly investment. Small caps, biotechs, commodities will all move faster one way or another but if one wants to just sit back and watch their investment gain value by the months and years PM is the way to go. Patience does not seem to be a virtue these days and getting rich is not easy. If it were we would not be writing these posts and hoping for the next home run. Nor would we be listening to the “experts”. Have you ever asked yourself, if the experts were so correct on their calls in the markets why are they not getting rich in the markets instead of pedaling their drivel….Have I got a deal for you!

      Come back to this post in five years.

    • If you want to get rich quick buy mining or infrastructure companies...there is a place for that in a portfolio. You can get poor quick also though.

      If you want to get rich over the long haul buy high yield safe steady growth stocks like PM, PG, MCD, ADP, KFT, etc. Minimal upside in the short term...more importantly minimal downside also.

    • US dollar down and market is up... How can PM do poorly today?

    • It took you 3 days to find out this information? This was announced on Tuesday...if you are not better at finding out information than that, you should not be investing in stocks.

    • Broker action

      Philip Morris International (PM 46.60, -0.22, -0.47%) was downgraded to neutral from buy at UBS, which said the cigarette maker is trading at a significant valuation premium to its peers.

    • LONDON (MarketWatch) -- Philip Morris International (PM 46.60, -0.22, -0.47%) (FR:PM 33.47, +0.01, +0.03%) was cut to neutral from buy at UBS, though the broker lifted the cigarette maker's price target to $47 from $45.50. "The stock has risen 40%+ since its March low point and is now trading on a significant valuation premium to its international and domestic peers," the brokerage said

101.53-0.19(-0.19%)Sep 23 4:01 PMEDT